Skip to main content

Table 2 Analysis of complication rates by preoperative sarcopenia

From: Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study

 

Preoperative

  

Sarcopenia

 

Level

No

Yes

p

(N = 23)

(N = 92)

30-day mortality (%)

 

0

(0.0)

3

(3.3)

0.884

90-day mortality (%)

 

1

(4.3)

6

(6.5)

1.000

Any complication (%)

 

17

(73.9)

62

(67.4)

0.725

Clavien-Dindo score (%)

0

6

(26.1)

30

(32.6)

0.886

 

1

0

(0.0)

3

(3.3)

 
 

2

4

(17.4)

10

(10.9)

 
 

3a

3

(13.0)

13

(14.1)

 
 

3b

7

(30.4)

20

(21.7)

 
 

4a

2

(8.7)

11

(12.0)

 
 

4b

0

(0.0)

2

(2.2)

 
 

5

1

(4.3)

3

(3.3)

 

Chyle leak (%)

 

1

(4.3)

8

(8.7)

0.795

Anastomotic leak (%)

 

2

(8.7

13

(14.1)

0.729

Conduit necrosis (%)

 

1

(4.3)

2

(2.2)

1.000

Recurrent nerve palsy (%)

 

1

(4.3)

7

(7.6)

0.927

Intraoperative Complications (%)

 

3

(13.0)

9

(9.8)

0.939

Pulmonary complications (%)

 

6

(26.1)

26

(28.3)

1.000

Reoperation rate (%)

 

2

(8.7)

8

(8.7)

1.000

Operative bleeding, ml (median [IQR])

 

200

[150, 400]

400

[150, 700]

0.091

ICU stay, days (median [IQR])

 

3

[1, 5]

2

[1, 4]

0.535

Tracheostomy rate (%)

 

1

(4.3)

8

(8.7)

0.795

  1. Intraoperative vessel, conduit or airway injury or conversion to open esophagectomy
  2. Contains ARDS (acute respiratory distress syndrome), pneumonia, atelectasis requiring intervention, pleural effusion or pneumothorax requiring intervention, pulmonary embolism, and acute aspiration